Hence, the SIRT1/Nrf2/NF-κB signal may become a potential therapeutic target to inhibit oxidative stress and inflammation, thereby exerting reno-protective effects in DN.At present, few few therapeutic agents directly target the renal and vascular complications of diabetes, and most studies focus on albuminuria. Here, SIRT1 is linked to liver dysplastic nodule.